388 related articles for article (PubMed ID: 9223389)
1. Measurement of markers of osteoclast and osteoblast activity in patients with acute and chronic diabetic Charcot neuroarthropathy.
Gough A; Abraha H; Li F; Purewal TS; Foster AV; Watkins PJ; Moniz C; Edmonds ME
Diabet Med; 1997 Jul; 14(7):527-31. PubMed ID: 9223389
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial.
Jude EB; Selby PL; Burgess J; Lilleystone P; Mawer EB; Page SR; Donohoe M; Foster AV; Edmonds ME; Boulton AJ
Diabetologia; 2001 Nov; 44(11):2032-7. PubMed ID: 11719835
[TBL] [Abstract][Full Text] [Related]
3. Calcaneal bone mineral density in patients with Charcot neuropathic osteoarthropathy: differences between Type 1 and Type 2 diabetes.
Petrova NL; Foster AV; Edmonds ME
Diabet Med; 2005 Jun; 22(6):756-61. PubMed ID: 15910628
[TBL] [Abstract][Full Text] [Related]
4. Role of body mass index in acute charcot neuroarthropathy.
Ross AJ; Mendicino RW; Catanzariti AR
J Foot Ankle Surg; 2013; 52(1):6-8. PubMed ID: 23260985
[TBL] [Abstract][Full Text] [Related]
5. Osteoprotegerin gene polymorphism in diabetic Charcot neuroarthropathy.
Korzon-Burakowska A; Jakóbkiewicz-Banecka J; Fiedosiuk A; Petrova N; Koblik T; Gabig-Cimińska M; Edmonds M; Małecki MT; Węgrzyn G
Diabet Med; 2012 Jun; 29(6):771-5. PubMed ID: 21913967
[TBL] [Abstract][Full Text] [Related]
6. Risk factors of charcot neuroarthropathy development in patients with type 2 diabetes.
Nehring P; Mrozikiewicz-Rakowska B; Maroszek P; Sobczyk-Kopcioł A; Krzyżewska M; Płoski R; Karnafel W
Exp Clin Endocrinol Diabetes; 2014 Jan; 122(1):31-4. PubMed ID: 24203651
[TBL] [Abstract][Full Text] [Related]
7. The role of genetic factors and monocyte-to-osteoclast differentiation in the pathogenesis of Charcot neuroarthropathy.
Kloska A; Korzon-Burakowska A; Malinowska M; Bruhn-Olszewska B; Gabig-Cimińska M; Jakóbkiewicz-Banecka J
Diabetes Res Clin Pract; 2020 Aug; 166():108337. PubMed ID: 32707214
[TBL] [Abstract][Full Text] [Related]
8. Charcot foot in diabetes: farewell to the neurotrophic theory.
Chantelau E; Onvlee GJ
Horm Metab Res; 2006 Jun; 38(6):361-7. PubMed ID: 16823717
[TBL] [Abstract][Full Text] [Related]
9. Charcot neuroarthropathy: An often overlooked complication of diabetes.
Botek G; Anderson MA; Taylor R
Cleve Clin J Med; 2010 Sep; 77(9):593-9. PubMed ID: 20810870
[TBL] [Abstract][Full Text] [Related]
10. Charcot neuroarthropathy triggered and complicated by osteomyelitis. How limb salvage can be achieved.
Aragón-Sánchez J; Lázaro-Martínez JL; Quintana-Marrero Y; Álvaro-Afonso FJ; Hernández-Herrero MJ
Diabet Med; 2013 Jun; 30(6):e229-32. PubMed ID: 23590722
[TBL] [Abstract][Full Text] [Related]
11. Recurrence of the acute Charcot foot in diabetes.
Rudrappa S; Game F; Jeffcoate W
Diabet Med; 2012 Jun; 29(6):819-21. PubMed ID: 22587408
[TBL] [Abstract][Full Text] [Related]
12. [Measurements and clinical usefulness of carboxyterminal propeptide of type I collagen and cross-linked carboxyterminal telopeptide of type I collagen in patients with prostate cancer].
Igawa T; Sakai H; Kanetake H; Saito Y
Hinyokika Kiyo; 1999 Apr; 45(4):235-9. PubMed ID: 10363141
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonates for the treatment of Charcot neuroarthropathy.
Anderson JJ; Woelffer KE; Holtzman JJ; Jacobs AM
J Foot Ankle Surg; 2004; 43(5):285-9. PubMed ID: 15480402
[TBL] [Abstract][Full Text] [Related]
14. Charcot neuroarthropathy in diabetes mellitus.
Rajbhandari SM; Jenkins RC; Davies C; Tesfaye S
Diabetologia; 2002 Aug; 45(8):1085-96. PubMed ID: 12189438
[TBL] [Abstract][Full Text] [Related]
15. The perils of procrastination: effects of early vs. delayed detection and treatment of incipient Charcot fracture.
Chantelau E
Diabet Med; 2005 Dec; 22(12):1707-12. PubMed ID: 16401316
[TBL] [Abstract][Full Text] [Related]
16. Use of bivalved ankle-foot orthosis in neuropathic foot and ankle lesions.
Boninger ML; Leonard JA
J Rehabil Res Dev; 1996 Feb; 33(1):16-22. PubMed ID: 8868413
[TBL] [Abstract][Full Text] [Related]
17. Asymmetrical attenuation of vibration sensation in unilateral diabetic Charcot foot neuroarthropathy.
Valabhji J; Marshall RC; Lyons S; Bloomfield L; Hogg D; Rosenfeld P; Gabriel CM
Diabet Med; 2012 Sep; 29(9):1191-4. PubMed ID: 22276944
[TBL] [Abstract][Full Text] [Related]
18. The Charcot joint in diabetes.
Klenerman L
Diabet Med; 1996; 13 Suppl 1():S52-4. PubMed ID: 8741831
[No Abstract] [Full Text] [Related]
19. Pressure pain thresholds at the diabetic Charcot-foot: an exploratory study.
Chantelau E; Wienemann T; Richter A
J Musculoskelet Neuronal Interact; 2012 Jun; 12(2):95-101. PubMed ID: 22647283
[TBL] [Abstract][Full Text] [Related]
20. [Charcot-arthropathy in diabetes mellitus].
Schoonbeek A; Ottens RL; Lutterman JA
Ned Tijdschr Geneeskd; 2002 Jan; 146(2):60-3. PubMed ID: 11820057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
